Rare diseases
Investigational molecules
Locations
Back to Italy39 clinical trials in Lucca, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
ItalyPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
ItalyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
ItalyPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
ItalyItalyStudy Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer
ItalyComparison of niraparib alone versus niraparib with bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel
ItalyStudy of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer
ItalyStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including novel combination therapies and targeted approaches for various disease stages.
Studies evaluating innovative drug sequences and therapeutic combinations to improve patient outcomes.
Comprehensive research on triple-negative breast cancer and hormone receptor-related conditions, investigating new treatment approaches.
Focus on improving treatment efficacy through novel drug combinations and sequencing strategies.
Trials examining treatments for ovarian cancer and endometrial cancer, with emphasis on maintenance therapies and novel drug combinations.
Investigation of targeted therapies and immunotherapy approaches for gynecologic cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
